Eton Pharmaceuticals (ETON) Treasury Shares (2018 - 2024)

Eton Pharmaceuticals has disclosed Treasury Shares across 5 years of filings, most recently posting $226068.0 for Q4 2024.

• Treasury Shares for Q4 2024 came in at $226068.0, down 17.55% year-over-year; the trailing twelve-month figure through Dec 2024 was $226068.0 (down 17.55% YoY), and the FY2024 annual result was $226068.0, down 17.55% from the prior year.
• Treasury Shares came in at $226068.0 for Q4 2024 at Eton Pharmaceuticals, down from $274204.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $369606.0 in Q3 2022 to a low of $7595.0 in Q4 2020.
• The 4-year median for Treasury Shares is $274204.0 (2023), against an average of $249415.8.
• Across the five-year window, Treasury Shares retreated 25.81% in 2023 and decreased 17.55% in 2024, its largest moves.
• Eton Pharmaceuticals' Treasury Shares stood at $7595.0 in 2020, then jumped by 4766.44% to $369606.0 in 2022, then declined by 25.81% to $274204.0 in 2023, then slipped by 17.55% to $226068.0 in 2024.
• The last three Treasury Shares figures came in at $226068.0 (Q4 2024), $274204.0 (Q4 2023), and $369606.0 (Q4 2022), per Business Quant data.